LOS ANGELES--(BUSINESS WIRE)--Feb. 12, 2005--Introducing Shugr -- the world's first truly natural, zero-calorie, diabetic-safe sweetener.
Shugr is a remarkable new sugar substitute that tastes and cooks like sugar, is tooth friendly and also contains pre-biotic fiber, which assists in healthful digestion. Due to overwhelming demand since its introduction last December, Shugr will now be available at major health food and natural products stores starting in March 2005, with expectations to be in mass drug and food stores nationwide by year end.
Shugr is made from a proprietary blend of erythritol, which occurs naturally in many fruits and vegetables, and tagatose, which provides added sweetness and pre-biotic fiber to aid digestion. This unique formulation results in a sweet taste that is remarkably like cane sugar with none of the aftertaste typically associated with other no calorie sweeteners. Shugr's formulation is patent pending and its ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety, as determined by the US Food & Drug Administration (FDA).
"High fructose corn syrup, sugar and artificial sweeteners are major health concerns today," said Loren Miles, CEO of Swiss Research, Inc., the maker of Swiss Diet Shugr. "Health officials and scientists are becoming increasingly alarmed about the possible link between these products and obesity, arguably the major health risk of our time. Shugr is the first natural, zero-calorie sweetener to provide consumers with a healthful alternative to what is presently on the market."
Leading zero-calorie sweeteners available today do not offer consumers a natural alternative. Splenda is made from sucralose, a synthetic ingredient, while Equal is made from aspartame, also a synthetic ingredient.
"Today marks an important step in the battle against obesity," continued Mr. Miles. "With Shugr, health-conscious people now have a natural, zero-calorie sweetener with a 'mouth-feel' quality that is nearly identical to that of cane sugar. Shugr is our Valentine's Day gift to the world!"
A recent Associated Press article reported that many food and beverage manufacturers may not be able to obtain sucralose this year as a result of a short supply. "We have received a flood of inquiries from food and beverage makers who are giving up on sucralose and wish to switch to Shugr," said Mr. Miles. "We have plenty of Shugr for everyone."
"Shugr is expected to be available in approximately 3,000 retail outlets including health food and other natural product stores as well as mass drug and food stores during the first quarter 2005," continued Miles. "We expect to announce a distribution deal with a major premium coffee house chain and a licensing agreement with a notable beverage and confection company in the coming months."
About Swiss Research, Inc.
Swiss Research, Inc. through its brands Swiss Research(R) and Swiss Diet(R) address weight-management, arthritis, cholesterol, diabetes, longevity and immune support with ethical, effective, clinically based products, that are accessible to consumers through mass drug, food and natural stores. Swiss Research, Inc. is a Health Sciences Group company.
About Health Sciences Group, Inc.
Health Sciences Group identifies, develops and commercializes innovative nutritional products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically-supported, FDA-approved ingredients under its Swiss Research(TM) and Swiss Diet(TM) brand names. For more information, visit www.HSciences.com.
Shugr and Swiss Diet are trademarks of Swiss Research, Inc. Splenda(R) is a trademark of McNeil Nutritionals, LLC. Equal(R) is a trademark of Merisant Corporation.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.